DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

97.16 -2.49 (-2.50%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $97.16 -2.50%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $99.14
Previous Close $99.65
Daily Range $96.89 - $100.90
52-Week Range $55.04 - $100.95
Market Cap $14.3B
P/E Ratio -113.24
Dividend (Yield) $0.00 (0.0%)
Volume 2,183,363
Average Daily Volume 1,343,085
Current FY EPS -$1.05

Sector

Healthcare

Industry

Drugs

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary

An $8 Billion Hedge Fund Bought This Extremely Risky Stock: Should You?

The healthcare gurus known as the Baker Brothers have amassed a huge position in the orphan drugmaker Synageva BioPharma Corp. Should investors follow in their footsteps?

Synageva Starts Dosing in Phase I/II Study for Sanfilippo B - Analyst Blog

New Lifetime High For Biomarin Pharmaceutical (BMRN)

Use Options For a Chance To Buy BMRN at a 24% Discount

Cramer on Stocks: 8 Signs the Market Is Remarkably Healthy

The Market Is Healthy - Cramer's Mad Money (1/26/15)

Jim Cramer's Top Stock Picks: BMRN HSY KMB

Jim Cramer's 'Mad Money' Recap: 8 Ways to Tell a Healthy Market From a Sick One

Forget Marijuana Stocks: Here Are 3 Smarter Investments

Three Motley Fool contributors offer up investing ideas that may be smarter than investing in marijuana.

'Mad Money' Lightning Round: Constellation Brands the New King in Town

See More BMRN News...

BMRN's Top Competitors

BMRN $97.16 (-2.50%)
Current stock: BMRN
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB